Article: News Analysis: Big Pharma mergers: a quick fix, not strategic

News Analysis: Big Pharma mergers: a quick fix, not strategic

BEIJING, March 14 (Xinhua) -- Swiss pharmaceutical giant Roche on Thursday announced plans to buy out California-based biotech pioneer Genetech for 46.8 billion U.S. dollars. The transaction is the latest megadeal in a burst of Big Pharma mergers.

What will consolidation bring to the industry? Will the tie-up lead to an upsurge in new drugs? Is acquisition a panacea for drugmakers facing increased cost pressures as key patents expire?

BURST OF HUGE MERGERS

Pfizer Inc., the world's largest drugmaker, said on Jan. 27 that it was buying rival Wyeth for 68 billion dollars in a deal to boost its revenue and diversification.

Pfizer ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!